Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Chlamydia Trachomatis
Screening for tubal pathology is improved with C-reactive protein test
August 4th, 2005
Screening for tubal pathology is improved with C-reactive protein test. "Persistent Chlamydia trachomatis infections are assumed to increase the risk of tubal pathology," scientists writing in the journal Human Reproduction report. J.E. den Hartog and fellow researchers, Akademisch Ziekenhuis Maastricht, studied "whether serological markers, assumed to be associated with persistent C. trachomatis infections, could identify subfertile women at risk of tubal pathology." They said, "Sera of 313 subfertile women, who all underwent a laparoscopy with tubal testing to assess the grade of tubal pathology, were tested...
Source: Women's Health Weekly (2005-08-04)
|
